Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020
NORCROSS, Ga., Sept. 22, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, […]